G01N2333/03 - CPC Classification Index

ClassID:

170232 ⎘

G01N2333/03 - CPC Classification

Classification description:

Assays involving biological materials from specific organisms or of a specific nature from viruses; DNA viruses Herpetoviridae, e.g. pseudorabies virus

Sub-classes:

G01N2333/032 » Pseudorabies virus, i.e. Aujetzky virus 0
G01N2333/035 » Herpes simplex virus I or II 28
G01N2333/04 » Varicella-zoster virus 13
G01N2333/05 » Epstein-Barr virus 42
G01N2333/055 » Marek's disease virus 0
G01N2333/06 » Infectious bovine rhinotracheitis virus 0

Recent Application in this class:

20250296984

2025-09-25

THERAPEUTIC AND DIAGNOSTIC AGENTS AND USES THEREOF

20250035625

2025-01-30

Lateral Flow Assay Device and Method for Rapid Detection of Antibodies Against Felis Catus Gammaherpesvirus 1 in Domestic Cat Blood

20240369546

2024-11-07

RED BLOOD CELL-DERIVED MAGNETIC IMMUNO-PARTICLE AND USE THEREOF

20240353409

2024-10-24

NOVEL SEROLOGY ASSAY FOR THE DETECTION OF PORCINE VIRUSES

20240248080

2024-07-25

Kaposi sarcoma associated herpesvirus gene function

20240085418

2024-03-14

Bovine Herpesvirus Detection and Treatment

20240011017

2024-01-11

METHODS FOR MODULATING HOST CELL SURFACE INTERACTIONS WITH HERPESVIRUSES

20220170933

2022-06-02

METHOD FOR DIAGNOSING AND STAGING HERPESVIRUS-MEDIATED NEURODEGENERATION

20220023417

2022-01-27

Methods of Selecting T Cell Line and Donor Thereof for Adoptive Cellular Therapy

#10

20210011017

2021-01-14

Bovine herpesvirus detection and treatment

#11

20200408777

2020-12-31

QUANTITATIVE BIOMARKERS OF EHV-1 SUSCEPTIBILITY AND PROTECTION

#12

20200110088

2020-04-09

Diagnosis and treatment of viral diseases

#13

20200072848

2020-03-05

Materials and methods for subjects at risk for viral reactivation

#14

20190086406

2019-03-21

Bovine herpesvirus detection and treatment

#15

20190025306

2019-01-24

Enzyme-linked immunoassay to detect gammaherpesvirus 1

#16

20190018022

2019-01-17

Method for diagnosing, treating, or preventing mood disorders

#17

20180180615

2018-06-28

Diagnosis and treatment of viral diseases

#18

20170319683

2017-11-09

Methods of selecting T cell line and donor thereof for adoptive cellular therapy

#19

20170168053

2017-06-15

Diagnosis and treatment of viral diseases

#20

20170101640

2017-04-13

Modulation of human cytomegalovirus replication by micro-RNA 132 (miR132), micro-RNA 145 (miR145) and micro-RNA 212 (miR212)

#21

20160377621

2016-12-29

Methods for the treatment of Kaposi's sarcoma or KSHV-induced lymphoma using immunomodulatory compounds, and uses of biomarkers

#22

20150344976

2015-12-03

Diagnosis and treatment of viral diseases

#23

20150328339

2015-11-19

Human glial chimeric model for drug candidate assessment in human gliotrophic viral infections and progressive multifocal encephalopathy

#24

20130034500

2013-02-07

Cationic Steroid Antimicrobial Compositions and Methods of Use

#25

20120178791

2012-07-12

Modulation of human cytomegalovirus replication by micro-RNA 132 (miR132), micro-RNA 145 (mi145) and micro-RNA 212 (miR212)

#26

20120129153

2012-05-24

Diagnostic method for the prediction of the development and control of the effectiveness of the treatment of oncological illnesses

#27

20120107842

2012-05-03

Method for detecting antibody against SITH-1 in biological sample

#28

20110294147

2011-12-01

Serological screening for HHV-8 infection using antigen mixtures

#29

20110053145

2011-03-03

QUANTITATION METHOD OF VIRUS

#30

20100330086

2010-12-30

Cationic steroid antimicrobial compositions and methods of use

#31

20100196375

2010-08-05

Engineered scFv against bovine herpes virus type I

#32

20100173280

2010-07-08

Systems for Detection and Production of Respiratory, Herpes and Enteric Viruses

#33

20100143440

2010-06-10

UL97 INHIBITORS FOR TREATMENT OF PROLIFERATIVE DISORDERS

#34

20080260687

2008-10-23

SPECIFIC BINDING AGENTS FOR KSHV vIL-6 THAT NEUTRALIZE A BIOLOGICAL ACTIVITY

#35

20070243162

2007-10-18

Specific binding agents for KSHV vIL-6 that neutralize a biological activity

#36

20070190558

2007-08-16

Cationic Steroid Antimicrobial Compositions and Methods of Use

#37

20070092898

2007-04-26

Detection of multiple anti-viral antibodies

#38

20070015197

2007-01-18

Specific binding agents for KSHV vIL-6 that neutralize a biological activity

#39

20060039927

2006-02-23

Specific binding agents for KSHV vIL-6 that neutralize a biological activity

#40

20060013828

2006-01-19

Immunizing fish against viral infection

#41

20050239052

2005-10-27

Cloning of rhadinovirus genome and methods for its use

#42

20050118572

2005-06-02

Single cell assessment of viral infection/replication

#43

20050032245

2005-02-10

Fluorescence polarization method for determining viral inhibitors